joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017. The company also has approvals in South Korea, China, Hong Kong, Indonesia, Singapore and Vietnam.
As of this year, the company will offer international courses on minimally invasive spinal surgery in conjunction with the Korean Wooridul group, reported to be the world’s largest specialized spine hospital network. Since 2004, >600 spine surgeons and specialists from 41 countries have participated in courses at Wooridul.
joimax systems for endoscopic minimally invasive spinal surgery include TESSYS® transforaminal, iLESSYS® interlaminar and CESSYS® cervical for decompression procedures, MultiZYTE® SI for SI joint therapy or with EndoLIF® and Percusys® for endoscopic minimally-invasive assisted stabilization. For 2016, the company announced sales growth of +31% vs. 2015.
Sources: joimax Inc.; ORTHOWORLD Inc.
joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017. The company also has approvals in South Korea, China, Hong Kong, Indonesia, Singapore and Vietnam.
As of this year, the company will offer international courses on minimally invasive...
joimax obtained full product registration from the Thai Food & Drug Administration. Certification in Japan, Malaysia and Taiwan is expected during 2017. The company also has approvals in South Korea, China, Hong Kong, Indonesia, Singapore and Vietnam.
As of this year, the company will offer international courses on minimally invasive spinal surgery in conjunction with the Korean Wooridul group, reported to be the world’s largest specialized spine hospital network. Since 2004, >600 spine surgeons and specialists from 41 countries have participated in courses at Wooridul.
joimax systems for endoscopic minimally invasive spinal surgery include TESSYS® transforaminal, iLESSYS® interlaminar and CESSYS® cervical for decompression procedures, MultiZYTE® SI for SI joint therapy or with EndoLIF® and Percusys® for endoscopic minimally-invasive assisted stabilization. For 2016, the company announced sales growth of +31% vs. 2015.
Sources: joimax Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.